I tried four vibe-coding tools, including Cursor and Replit, with no coding background. Here's what worked (and what didn't).

A new digital system allows operations on a chip to run in parallel, so an AI program can arrive at the best possible answer ...

The West Virginia Mountaineers looked absolutely dominant on Sunday as they crushed Houston in the opening match-up of their Big 12 schedule, running away to 101-46 victory at the Hope Coliseum in ...

ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling 'unprecedented.' Major pharmaceutical developers such as ...

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase 2 multiple myeloma trial, paving the way for smoother and more effective ...

Wednesday night was a historic performance all around for the No. 10 Iowa State Cyclones in a 132-68 rout over Alcorn State. A win over the 1-9 Braves from the SWAC would not typically generate a lot ...

The Second City New York will expand its holiday programming this season with a range of improv productions scheduled throughout December. The lineup will include family-friendly weekend performances ...

With the rapid development of code intelligence, the application of multiple programming languages is becoming increasingly widespread. However, most existing code generation models mainly focus on a ...

In a post on the social media platform X on Thursday, influencer Sawyer Merritt shared that the automaker was expanding its rental program across multiple cities in the U.S., citing a series of job ...

Argus (WMSM-915), the first ship of the heritage class of medium endurance offshore patrol cutters, enters the water during a christening ceremony in Panama City, Fla., Oct. 27, 2023. US Coast Guard ...

A new state report has cited a Stillwater-area substance abuse treatment program for more than 100 breaches of state law or rules, confirming what whistleblowers long suspected. Last summer, several ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...